Health Economics & Outcomes Research (HEOR) | Real World Evidence (RWE)

We can help you develop your product's value story to reveal business insights for better decision-making.

KMK has extensive experience in working with a variety of Real World Data (RWD), including administrative claims data, electronic health records, registries, and government databases.

Communicate your unique value proposition to key stakeholders:

Regulators:  Provide all the data and support documentation to understand the exposure, epidemiology, conditions for use, characteristics of patients receiving the product, safety concerns and risk factors
Providers: Help them make an informed decision to prescribe a drug based on strong clinical data in the patient populations most likely to respond to treatment
Payers: Educate them to the burden of the disease, conditions for use, expected clinical and economic benefits, and the potential for addressing unmet medical needs
Patients: Initiate them to comply with the therapy when the drug benefits are apparent, their experience is improved, and costs are perceived to be reasonable

That's were KMK can help. We deep dive into the data with rigorous scientific methodologies and advanced Big Data processing tools to generate the Real World Evidence (RWE) you need to communicate effectively on the value of your product.

Disease Landscape

BETTER UNDERSTANDING. ON-TARGET DEVELOPMENT

KMK will make sure you have the RWE needed to make better decisions and jump start your development strategy.

Patient Journey

JOURNEY ASSESSED. OPPORTUNITIES REVEALED

Understanding how patients and caregivers respond during each phase of a disease is critical to communicating effectively and maintaining patient adherence to treatment protocols.